Modulation of dendritic cell differentiation and maturation by decoy receptor 3

Tsui Ling Hsu, Yung Chi Chang, Siu Ju Chen, Yong Jun Liu, Allen W. Chiu, Chung Ching Chio, Lieping Chen, Shie Liang Hsieh

Research output: Contribution to journalArticle

Abstract

Decoy receptor 3 (DcR3), a soluble receptor belonging to the TNFR superfamily, is a receptor for both Fas ligand (FasL) and LIGHT. It has been demonstrated that DcR3 is up-regulated in lung and colon cancers, thus promoting tumor growth by neutralizing the cytotoxic effects of FasL and LIGHT. In this study, we found that DcR3.Fc profoundly modulated dendritic cell differentiation and maturation from CD14+ monocytes, including the up-regulation of CD86/B7.2, and the down-regulation of CD40, CD54/ICAM-1, CD80/B7.1, CD1a, and HLA-DR. Moreover, DcR3-treated dendritic cells suppressed CD4+ T cell proliferation in an allogeneic MLR and up-regulated IL-4 secretion of CD4+CD45RA+ T cells. This suggests that DcR3.Fc may act not only as a decoy receptor to FasL and LIGHT, but also as an effector molecule to skew T cell response to the Th2 phenotype.

Original languageEnglish (US)
Pages (from-to)4846-4853
Number of pages8
JournalJournal of Immunology
Volume168
Issue number10
StatePublished - May 15 2002
Externally publishedYes

Fingerprint

Fas Ligand Protein
Dendritic Cells
Cell Differentiation
T-Lymphocytes
Light
HLA-DR Antigens
Intercellular Adhesion Molecule-1
Interleukin-4
Colonic Neoplasms
Monocytes
Lung Neoplasms
Up-Regulation
Down-Regulation
Cell Proliferation
Phenotype
Growth
Neoplasms

ASJC Scopus subject areas

  • Immunology

Cite this

Hsu, T. L., Chang, Y. C., Chen, S. J., Liu, Y. J., Chiu, A. W., Chio, C. C., ... Hsieh, S. L. (2002). Modulation of dendritic cell differentiation and maturation by decoy receptor 3. Journal of Immunology, 168(10), 4846-4853.

Modulation of dendritic cell differentiation and maturation by decoy receptor 3. / Hsu, Tsui Ling; Chang, Yung Chi; Chen, Siu Ju; Liu, Yong Jun; Chiu, Allen W.; Chio, Chung Ching; Chen, Lieping; Hsieh, Shie Liang.

In: Journal of Immunology, Vol. 168, No. 10, 15.05.2002, p. 4846-4853.

Research output: Contribution to journalArticle

Hsu, TL, Chang, YC, Chen, SJ, Liu, YJ, Chiu, AW, Chio, CC, Chen, L & Hsieh, SL 2002, 'Modulation of dendritic cell differentiation and maturation by decoy receptor 3', Journal of Immunology, vol. 168, no. 10, pp. 4846-4853.
Hsu TL, Chang YC, Chen SJ, Liu YJ, Chiu AW, Chio CC et al. Modulation of dendritic cell differentiation and maturation by decoy receptor 3. Journal of Immunology. 2002 May 15;168(10):4846-4853.
Hsu, Tsui Ling ; Chang, Yung Chi ; Chen, Siu Ju ; Liu, Yong Jun ; Chiu, Allen W. ; Chio, Chung Ching ; Chen, Lieping ; Hsieh, Shie Liang. / Modulation of dendritic cell differentiation and maturation by decoy receptor 3. In: Journal of Immunology. 2002 ; Vol. 168, No. 10. pp. 4846-4853.
@article{06cb7c5f8704491ba50f94f070ffe588,
title = "Modulation of dendritic cell differentiation and maturation by decoy receptor 3",
abstract = "Decoy receptor 3 (DcR3), a soluble receptor belonging to the TNFR superfamily, is a receptor for both Fas ligand (FasL) and LIGHT. It has been demonstrated that DcR3 is up-regulated in lung and colon cancers, thus promoting tumor growth by neutralizing the cytotoxic effects of FasL and LIGHT. In this study, we found that DcR3.Fc profoundly modulated dendritic cell differentiation and maturation from CD14+ monocytes, including the up-regulation of CD86/B7.2, and the down-regulation of CD40, CD54/ICAM-1, CD80/B7.1, CD1a, and HLA-DR. Moreover, DcR3-treated dendritic cells suppressed CD4+ T cell proliferation in an allogeneic MLR and up-regulated IL-4 secretion of CD4+CD45RA+ T cells. This suggests that DcR3.Fc may act not only as a decoy receptor to FasL and LIGHT, but also as an effector molecule to skew T cell response to the Th2 phenotype.",
author = "Hsu, {Tsui Ling} and Chang, {Yung Chi} and Chen, {Siu Ju} and Liu, {Yong Jun} and Chiu, {Allen W.} and Chio, {Chung Ching} and Lieping Chen and Hsieh, {Shie Liang}",
year = "2002",
month = "5",
day = "15",
language = "English (US)",
volume = "168",
pages = "4846--4853",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - Modulation of dendritic cell differentiation and maturation by decoy receptor 3

AU - Hsu, Tsui Ling

AU - Chang, Yung Chi

AU - Chen, Siu Ju

AU - Liu, Yong Jun

AU - Chiu, Allen W.

AU - Chio, Chung Ching

AU - Chen, Lieping

AU - Hsieh, Shie Liang

PY - 2002/5/15

Y1 - 2002/5/15

N2 - Decoy receptor 3 (DcR3), a soluble receptor belonging to the TNFR superfamily, is a receptor for both Fas ligand (FasL) and LIGHT. It has been demonstrated that DcR3 is up-regulated in lung and colon cancers, thus promoting tumor growth by neutralizing the cytotoxic effects of FasL and LIGHT. In this study, we found that DcR3.Fc profoundly modulated dendritic cell differentiation and maturation from CD14+ monocytes, including the up-regulation of CD86/B7.2, and the down-regulation of CD40, CD54/ICAM-1, CD80/B7.1, CD1a, and HLA-DR. Moreover, DcR3-treated dendritic cells suppressed CD4+ T cell proliferation in an allogeneic MLR and up-regulated IL-4 secretion of CD4+CD45RA+ T cells. This suggests that DcR3.Fc may act not only as a decoy receptor to FasL and LIGHT, but also as an effector molecule to skew T cell response to the Th2 phenotype.

AB - Decoy receptor 3 (DcR3), a soluble receptor belonging to the TNFR superfamily, is a receptor for both Fas ligand (FasL) and LIGHT. It has been demonstrated that DcR3 is up-regulated in lung and colon cancers, thus promoting tumor growth by neutralizing the cytotoxic effects of FasL and LIGHT. In this study, we found that DcR3.Fc profoundly modulated dendritic cell differentiation and maturation from CD14+ monocytes, including the up-regulation of CD86/B7.2, and the down-regulation of CD40, CD54/ICAM-1, CD80/B7.1, CD1a, and HLA-DR. Moreover, DcR3-treated dendritic cells suppressed CD4+ T cell proliferation in an allogeneic MLR and up-regulated IL-4 secretion of CD4+CD45RA+ T cells. This suggests that DcR3.Fc may act not only as a decoy receptor to FasL and LIGHT, but also as an effector molecule to skew T cell response to the Th2 phenotype.

UR - http://www.scopus.com/inward/record.url?scp=0037093990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037093990&partnerID=8YFLogxK

M3 - Article

C2 - 11994433

AN - SCOPUS:0037093990

VL - 168

SP - 4846

EP - 4853

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -